ECB-ART-49499
Mar Drugs
2020 Nov 09;1811:. doi: 10.3390/md18110557.
Show Gene links
Show Anatomy links
Pharmacokinetics of Marine-Derived Drugs.
Shikov AN
,
Flisyuk EV
,
Obluchinskaya ED
,
Pozharitskaya ON
.
???displayArticle.abstract???
Marine organisms represent an excellent source of innovative compounds that have the potential for the development of new drugs. The pharmacokinetics of marine drugs has attracted increasing interest in recent decades due to its effective and potential contribution to the selection of rational dosage recommendations and the optimal use of the therapeutic arsenal. In general, pharmacokinetics studies how drugs change after administration via the processes of absorption, distribution, metabolism, and excretion (ADME). This review provides a summary of the pharmacokinetics studies of marine-derived active compounds, with a particular focus on their ADME. The pharmacokinetics of compounds derived from algae, crustaceans, sea cucumber, fungus, sea urchins, sponges, mollusks, tunicate, and bryozoan is discussed, and the pharmacokinetics data in human experiments are analyzed. In-depth characterization using pharmacokinetics is useful for obtaining information for understanding the molecular basis of pharmacological activity, for correct doses and treatment schemes selection, and for more effective drug application. Thus, an increase in pharmacokinetic research on marine-derived compounds is expected in the near future.
???displayArticle.pubmedLink??? 33182407
???displayArticle.pmcLink??? PMC7698100
???displayArticle.link??? Mar Drugs
???displayArticle.grants??? [+]
N.A. MMBI RAS, Ministry of Education and Science of the RF
???attribute.lit??? ???displayArticles.show???
|
|
Figure 1. Structures of marine-derived compounds: fucoidan (1); alginic acid (2); halomon (3); eckol (4); fucoxanthin (5); astaxanthin (6); chitosan (7); echinoside A (8); holothurin A (9); holotoxin A1 (10); frondoside A (11); cucumarioside A2-2 (12); 6-epi-ophiobolin G (13); diindolinonepyrane (14); ilimaquinone (15); manzamine A (16); echinochrome A (17); aplidine (18); kahalalide F (19); dolastatin 10 (20); dolastatin 15 (21); bryostatin 1 (22); fucoxanthinol (23); amarouciaxanthin A (24); ecteinascidin 743 (25). |
References [+] :
Aherne,
Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay.
1996, Pubmed
Aherne, Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay. 1996, Pubmed
Al Shemaili, Pharmacokinetics in Mouse and Comparative Effects of Frondosides in Pancreatic Cancer. 2016, Pubmed , Echinobase
Aminin, Anticancer activity of sea cucumber triterpene glycosides. 2015, Pubmed , Echinobase
Aminin, The use of tritium-labeled triterpene glycosides from the holothurian Cucumaria japonica in pharmacokinetic studies. 2008, Pubmed , Echinobase
Ang, In vivo antimalarial activity of the beta-carboline alkaloid manzamine A. 2000, Pubmed
Asai, Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites. 2004, Pubmed
Bae, Health benefits of fucoxanthin in the prevention of chronic diseases. 2020, Pubmed
Bai, Study on Absorption Mechanism and Tissue Distribution of Fucoidan. 2020, Pubmed
Barbosa, Marine Polysaccharides in Pharmaceutical Applications: Fucoidan and Chitosan as Key Players in the Drug Delivery Match Field. 2019, Pubmed
Barkia, Microalgae for High-Value Products Towards Human Health and Nutrition. 2019, Pubmed
Barton, Pharmacokinetics of the Antiviral Lectin Griffithsin Administered by Different Routes Indicates Multiple Potential Uses. 2016, Pubmed
Barton, Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models. 2014, Pubmed
Ben, Major vault protein regulates class A scavenger receptor-mediated tumor necrosis factor-α synthesis and apoptosis in macrophages. 2013, Pubmed
Bergström, Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs. 2014, Pubmed
Bian, Recent Advances on Marine Alkaloids from Sponges. 2020, Pubmed
Blunt, Marine natural products. 2016, Pubmed
Blunt, Marine natural products. 2017, Pubmed , Echinobase
Blunt, Marine natural products. 2018, Pubmed
Bordbar, High-value components and bioactives from sea cucumbers for functional foods--a review. 2011, Pubmed , Echinobase
Cao, Current Research Landscape of Marine-Derived Anti-Atherosclerotic Substances. 2020, Pubmed
Carroll, Marine natural products. 2019, Pubmed
Carroll, Marine natural products. 2020, Pubmed , Echinobase
Celli, Analysis of aplidine (dehydrodidemnin B), a new marine-derived depsipeptide, in rat biological fluids by liquid chromatography-tandem mass spectrometry. 1999, Pubmed
Chae, Influence of molecular weight on oral absorption of water soluble chitosans. 2005, Pubmed
Chaki, Metabolism and calcium antagonism of sodium alginate oligosaccharides. 2007, Pubmed
Choi, Pharmacokinetics and first-pass metabolism of astaxanthin in rats. 2011, Pubmed
Ciavatta, Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance. 2017, Pubmed
Citkowska, Possibilities of Fucoidan Utilization in the Development of Pharmaceutical Dosage Forms. 2019, Pubmed , Echinobase
Cotas, Seaweed Phenolics: From Extraction to Applications. 2020, Pubmed
Cunha, Sulfated Seaweed Polysaccharides as Multifunctional Materials in Drug Delivery Applications. 2016, Pubmed
Dorr, Phase I clinical and pharmacokinetic investigation of didemnin B, a cyclic depsipeptide. 1988, Pubmed
Egorin, Plasma pharmacokinetics, bioavailability, and tissue distribution in CD2F1 mice of halomon, an antitumor halogenated monoterpene isolated from the red algae Portieria hornemannii. 1996, Pubmed
Egorin, In vitro metabolism by mouse and human liver preparations of halomon, an antitumor halogenated monoterpene. 1997, Pubmed
El-Demerdash, Chemistry and Biological Activities of the Marine Sponges of the Genera Mycale (Arenochalina), Biemna and Clathria. 2018, Pubmed
El-Demerdash, Chemical Diversity and Biological Activities of Marine Sponges of the Genus Suberea: A Systematic Review. 2019, Pubmed
Faircloth, Kahalalide F and ES285: potent anticancer agents from marine molluscs. 2006, Pubmed
Faivre, Phase I and pharmacokinetic study of aplidine, a new marine cyclodepsipeptide in patients with advanced malignancies. 2005, Pubmed
Fedoreyev, Antiviral and Antioxidant Properties of Echinochrome A. 2018, Pubmed , Echinobase
Fitton, Therapies from Fucoidan: New Developments. 2019, Pubmed
Fu, Chinese Marine Materia Medica Resources: Status and Potential. 2016, Pubmed
Fuller, A pentahalogenated monoterpene from the red alga Portieria hornemannii produces a novel cytotoxicity profile against a diverse panel of human tumor cell lines. 1992, Pubmed
Galasso, On the Neuroprotective Role of Astaxanthin: New Perspectives? 2018, Pubmed
Gammone, Anti-obesity activity of the marine carotenoid fucoxanthin. 2015, Pubmed
Garteiz, Quantitation of dolastatin-10 using HPLC/electrospray ionization mass spectrometry: application in a phase I clinical trial. 1998, Pubmed
Giannaccare, Clinical Applications of Astaxanthin in the Treatment of Ocular Diseases: Emerging Insights. 2020, Pubmed
Guseva, [The specific features of penetration of the antioxidant histochrome across the blood-ocular barrier: an experimental study]. 2007, Pubmed
Hao, An Overview of the Protective Effects of Chitosan and Acetylated Chitosan Oligosaccharides against Neuronal Disorders. 2017, Pubmed
Hasan, Major bioactive metabolites from marine fungi: A Review. 2015, Pubmed
Hashimoto, The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice. 2009, Pubmed
Hochhaus, Evolution of pharmacokinetics and pharmacokinetic/dynamic correlations during the 20th century. 2000, Pubmed
Hu, Neuroprotective role of fucoxanthin against cerebral ischemic/reperfusion injury through activation of Nrf2/HO-1 signaling. 2018, Pubmed
Humphreys, Absorption by the rat of alginate labelled with carbon-14. 1968, Pubmed
Imbs, Is the transformation of fucoidans in human body possible? 2020, Pubmed
Inui, Cellular and molecular aspects of drug transport in the kidney. 2000, Pubmed
Irhimeh, A quantitative method to detect fucoidan in human plasma using a novel antibody. 2005, Pubmed
Jin, Differential effects of triterpene glycosides, frondoside A and cucumarioside A2-2 isolated from sea cucumbers on caspase activation and apoptosis of human leukemia cells. 2009, Pubmed , Echinobase
Kadena, Absorption Study of Mozuku Fucoidan in Japanese Volunteers. 2018, Pubmed
Katanaev, The Anticancer Drug Discovery Potential of Marine Invertebrates from Russian Pacific. 2019, Pubmed
Khotimchenko, Pharmacological Potential of Sea Cucumbers. 2018, Pubmed , Echinobase
Kim, Echinochrome A Attenuates Cerebral Ischemic Injury through Regulation of Cell Survival after Middle Cerebral Artery Occlusion in Rat. 2019, Pubmed , Echinobase
Krishnaswami, Biological macromolecules for ophthalmic drug delivery to treat ocular diseases. 2018, Pubmed
Krylova, The Comparative Analysis of Antiviral Activity of Native and Modified Fucoidans from Brown Algae Fucus evanescens In Vitro and In Vivo. 2020, Pubmed
Kuznetsova, Immunoadjuvant Activity of Fucoidans from the Brown Alga Fucus evanescens. 2020, Pubmed
Landon, Impact of Astaxanthin on Diabetes Pathogenesis and Chronic Complications. 2020, Pubmed
Le Tourneau, Reports of clinical benefit of plitidepsin (Aplidine), a new marine-derived anticancer agent, in patients with advanced medullary thyroid carcinoma. 2010, Pubmed
Lee, Griffithsin, a Highly Potent Broad-Spectrum Antiviral Lectin from Red Algae: From Discovery to Clinical Application. 2019, Pubmed
Lee, Activation of p53 with ilimaquinone and ethylsmenoquinone, marine sponge metabolites, induces apoptosis and autophagy in colon cancer cells. 2015, Pubmed
Li, Absorption and Transport of Sea Cucumber Saponins from Apostichopus japonicus. 2016, Pubmed , Echinobase
Li, Review of the apoptosis pathways in pancreatic cancer and the anti-apoptotic effects of the novel sea cucumber compound, Frondoside A. 2008, Pubmed , Echinobase
Lin, Manzamine A Exerts Anticancer Activity against Human Colorectal Cancer Cells. 2018, Pubmed
Ma, Evaluation of Marine Diindolinonepyrane in Vitro and in Vivo: Permeability Characterization in Caco-2 Cells Monolayer and Pharmacokinetic Properties in Beagle Dogs. 2019, Pubmed
Ma, Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2. 2012, Pubmed , Echinobase
Manandhar, Characterizing Eckol as a Therapeutic Aid: A Systematic Review. 2019, Pubmed
Martín-Algarra, Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma. 2009, Pubmed
Mayer, Marine Pharmacology in 2014-2015: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, Antiviral, and Anthelmintic Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action. 2019, Pubmed
Menchinskaya, Antitumor activity of cucumarioside A2-2. 2013, Pubmed , Echinobase
Mercke Odeberg, Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. 2003, Pubmed
Michel, In vitro fermentation by human faecal bacteria of total and purified dietary fibres from brown seaweeds. 1996, Pubmed
Moraru, A Meta-Analysis on Randomised Controlled Clinical Trials Evaluating the Effect of the Dietary Supplement Chitosan on Weight Loss, Lipid Parameters and Blood Pressure. 2018, Pubmed
Mori, Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. 2005, Pubmed
Nagamine, Intestinal absorption of fucoidan extracted from the brown seaweed, Cladosiphon okamuranus. 2014, Pubmed
Nakazato, Attenuation of N-nitrosodiethylamine-induced liver fibrosis by high-molecular-weight fucoidan derived from Cladosiphon okamuranus. 2010, Pubmed
Nalda-Molina, Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjects. 2009, Pubmed
Nelson, Adduct formation in liquid chromatography-triple quadrupole mass spectrometric measurement of bryostatin 1. 2014, Pubmed
Newman, Preclinical pharmacology of the natural marine product dolastatin 10 (NSC 376128). 1994, Pubmed
Newman, Marine natural products and related compounds in clinical and advanced preclinical trials. 2004, Pubmed
Nishikawa, Detection and pharmacokinetics of alginate oligosaccharides in mouse plasma and urine after oral administration by a liquid chromatography/tandem mass spectrometry (LC-MS/MS) method. 2008, Pubmed
Okada, Bioavailability of astaxanthin in Haematococcus algal extract: the effects of timing of diet and smoking habits. 2009, Pubmed
Onishi, Biodegradation and distribution of water-soluble chitosan in mice. 1999, Pubmed
Pangestuti, Medicinal and health benefit effects of functional sea cucumbers. 2018, Pubmed , Echinobase
Pardo, Phase I clinical and pharmacokinetic study of kahalalide F administered weekly as a 1-hour infusion to patients with advanced solid tumors. 2008, Pubmed
Paudel, Eckol as a Potential Therapeutic against Neurodegenerative Diseases Targeting Dopamine D₃/D₄ Receptors. 2019, Pubmed
Petri, Tissue distribution of astaxanthin in rats following exposure to graded levels in the feed. 2007, Pubmed
Pislyagin, Determination of cucumarioside A₂-2 in mouse spleen by radiospectroscopy, MALDI-MS and MALDI-IMS. 2013, Pubmed
Pislyagin, Cucumarioside A₂-2 Causes Macrophage Activation in Mouse Spleen. 2017, Pubmed , Echinobase
Pozharitskaya, Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats. 2018, Pubmed
Pozharitskaya, The Pharmacokinetics of Fucoidan after Topical Application to Rats. 2019, Pubmed
Pozharitskaya, Mechanisms of Bioactivities of Fucoidan from the Brown Seaweed Fucus vesiculosus L. of the Barents Sea. 2020, Pubmed
Prokopov, Animal-derived medicinal products in Russia: Current nomenclature and specific aspects of quality control. 2019, Pubmed
Rademaker-Lakhai, Phase I clinical and pharmacokinetic study of kahalalide F in patients with advanced androgen refractory prostate cancer. 2005, Pubmed
Raghuvanshi, Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review. 2020, Pubmed
Richardson, Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. 1999, Pubmed
Rosa, Seaweed Secondary Metabolites with Beneficial Health Effects: An Overview of Successes in In Vivo Studies and Clinical Trials. 2019, Pubmed
Shang, Traditional Chinese medicine--sea urchin. 2014, Pubmed , Echinobase
Shikov, Pharmacokinetic Study of Bioactive Glycopeptide from Strongylocentrotus droebachiensis After Intranasal Administration to Rats Using Biomarker Approach. 2019, Pubmed , Echinobase
Simmons, Marine natural products as anticancer drugs. 2005, Pubmed
Son, Stereo-Selective Pharmacokinetics of Ilimaquinone Epimers Extracted from a Marine Sponge in Rats. 2019, Pubmed
Son, HPLC-MS/MS analysis of ilimaquinone and its application in a pharmacokinetic study in rats. 2019, Pubmed
Song, Characterization of Metabolic Pathways and Absorption of Sea Cucumber Saponins, Holothurin A and Echinoside A, in Vitro and in Vivo. 2017, Pubmed , Echinobase
Sorrenti, Astaxanthin as a Putative Geroprotector: Molecular Basis and Focus on Brain Aging. 2020, Pubmed
Su, Pharmacokinetics and tissue distribution of a novel marine fibrinolytic compound in Wistar rat following intravenous administrations. 2013, Pubmed
Suda, Kupffer cells play important roles in the metabolic degradation of a soluble anti-tumor (1-->3)-beta-D-glucan, SSG, in mice. 1996, Pubmed
Sugawara, Brown algae fucoxanthin is hydrolyzed to fucoxanthinol during absorption by Caco-2 human intestinal cells and mice. 2002, Pubmed
Sun, Bryostatin-1: pharmacology and therapeutic potential as a CNS drug. 2006, Pubmed
Suárez, Kahalalide F, a new marine-derived compound, induces oncosis in human prostate and breast cancer cells. 2003, Pubmed
Talalaeva, [Identification of histochrome metabolism products in urine for studying drug pharmacokinetics]. 2014, Pubmed
Thanou, Chitosan and its derivatives as intestinal absorption enhancers. 2001, Pubmed
Tian, Toxicity, Pharmacokinetics, and Gut Microbiome of Oral Administration of Sesterterpene MHO7 Derived from a Marine Fungus. 2019, Pubmed
Tian, The Biological Activities of Sesterterpenoid-Type Ophiobolins. 2017, Pubmed
Tokita, Development of a fucoidan-specific antibody and measurement of fucoidan in serum and urine by sandwich ELISA. 2010, Pubmed
Tokita, Detection of Fucoidan in Urine after Oral Intake of Traditional Japanese Seaweed, Okinawa mozuku (Cladosiphon okamuranus Tokida). 2017, Pubmed
Tomori, Are Helicobacter pylori Infection and Fucoidan Consumption Associated with Fucoidan Absorption? 2020, Pubmed
Twelves, Phase I and pharmacokinetic study of Yondelis (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours. 2003, Pubmed
Tziveleka, Natural products with anti-HIV activity from marine organisms. 2003, Pubmed , Echinobase
Uyen, Fabrication of alginate microspheres for drug delivery: A review. 2020, Pubmed
Wang, The protective effect of fucoidan in rats with streptozotocin-induced diabetic nephropathy. 2014, Pubmed
Yamamoto, Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas. 2011, Pubmed
Yan, Effects of a novel marine natural product: pyrano indolone alkaloid fibrinolytic compound on thrombolysis and hemorrhagic activities in vitro and in vivo. 2015, Pubmed
Yousaf, New manzamine alkaloids from an Indo-Pacific sponge. Pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases. 2004, Pubmed
Youssef, A Comprehensive Review of Bioactive Peptides from Marine Fungi and Their Biological Significance. 2019, Pubmed
Yuan, Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae. 2011, Pubmed
Yun, Holotoxin A₁ Induces Apoptosis by Activating Acid Sphingomyelinase and Neutral Sphingomyelinase in K562 and Human Primary Leukemia Cells. 2018, Pubmed , Echinobase
Zakirova, [Pharmacokinetics and clinical efficacy of histochrome in patients with acute myocardial infarction]. 1997, Pubmed
Zangarini, Quantification of trabectedin in human plasma: validation of a high-performance liquid chromatography-mass spectrometry method and its application in a clinical pharmacokinetic study. 2014, Pubmed
Zhan, Determination of fucoidan in rat plasma by HPLC and its application in pharmacokinetics. 2020, Pubmed
Zhang, Simultaneous Determination of Fucoxanthin and Its Deacetylated Metabolite Fucoxanthinol in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry. 2015, Pubmed
Zhang, Preclinical pharmacology of the natural product anticancer agent bryostatin 1, an activator of protein kinase C. 1996, Pubmed
Zhang, Multiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin. 2015, Pubmed
Zhang, Effects of fucoidan on chronic renal failure in rats. 2003, Pubmed
Zhao, Antithrombotic activity of oral administered low molecular weight fucoidan from Laminaria Japonica. 2016, Pubmed
Zhao, In vitro and in vivo anti-tumour activities of echinoside A and ds-echinoside A from Pearsonothuria graeffei. 2012, Pubmed , Echinobase
Zheng, Protective Effects of Fucoxanthin against Alcoholic Liver Injury by Activation of Nrf2-Mediated Antioxidant Defense and Inhibition of TLR4-Mediated Inflammation. 2019, Pubmed
d'Ayala, Marine derived polysaccharides for biomedical applications: chemical modification approaches. 2008, Pubmed
van Andel, Review of Chromatographic Bioanalytical Assays for the Quantitative Determination of Marine-Derived Drugs for Cancer Treatment. 2018, Pubmed
van Kesteren, Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study. 2000, Pubmed
van Weelden, Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms. 2019, Pubmed
Østerlie, Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. 2000, Pubmed